GILD - Gilead Sciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 94.90B
Enterprise value 114.27B
Trailing P/E 17.21
Forward P/E 11.19
PEG Ratio (5 yr expected) 0.55
Price/sales (ttm)3.55
Price/book (mrq)4.52
Enterprise value/revenue 4.23
Enterprise value/EBITDA 10.98

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 324.35%
S&P500 52-week change 36.21%
52-week high 389.74
52-week low 357.17
50-day moving average 380.60
200-day moving average 378.42

Share statistics

Avg vol (3-month) 35.5M
Avg vol (10-day) 36.06M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.10%
% held by institutions 185.97%
Shares short (14 May 2023) 417.98M
Short ratio (14 May 2023) 43.36
Short % of float (14 May 2023) 41.61%
Short % of shares outstanding (14 May 2023) 41.44%
Shares short (prior month 13 Apr 2023) 415.25M

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 43.94%
Trailing annual dividend rate 32.94
Trailing annual dividend yield 33.86%
5-year average dividend yield 43.86
Payout ratio 466.52%
Dividend date 328 Jun 2023
Ex-dividend date 413 Jun 2023
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 20.65%
Operating margin (ttm)37.87%

Management effectiveness

Return on assets (ttm)10.24%
Return on equity (ttm)27.11%

Income statement

Revenue (ttm)27.04B
Revenue per share (ttm)21.58
Quarterly revenue growth (yoy)-3.60%
Gross profit (ttm)21.62B
Net income avi to common (ttm)5.58B
Diluted EPS (ttm)4.52
Quarterly earnings growth (yoy)5,215.80%

Balance sheet

Total cash (mrq)6.52B
Total cash per share (mrq)5.22
Total debt (mrq)25.24B
Total debt/equity (mrq)120.54
Current ratio (mrq)1.28
Book value per share (mrq)16.83

Cash flow statement

Operating cash flow (ttm)8.98B
Levered free cash flow (ttm)8.51B